Back to Search
ARKADI CHINES, MD
MD
Endocrinology, Diabetes & Metabolism Physician
NPI: 1831423979Individual
Specialties, Licenses & Credentials
Endocrinology, Diabetes & Metabolism PhysicianPrimary
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
MD438164(PA)
Research & Publications (19)
Vitamin D status, parathyroid function, bone turnover, and BMD in postmenopausal women with osteoporosis: global perspective.
PMID 19049341·J Bone Miner Res·2009
8-other
Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial.
PMID 18665787·J Bone Miner Res·2008
3-trial
Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study.
PMID 18072873·J Bone Miner Res·2008
2-rct
Fracture risk remains reduced one year after discontinuation of risedronate.
PMID 17938986·Osteoporos Int·2008
2-rct
Clinical evaluation of medicinal products for acceleration of fracture healing in patients with osteoporosis.
PMID 18544475·Bone·2008
6-review
Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by three-dimensional microcomputed tomography.
PMID 15050906·Bone·2004
3-trial
Five years of treatment with risedronate and its effects on bone safety in women with postmenopausal osteoporosis.
PMID 15478000·Calcif Tissue Int·2004
3-trial
Two-year efficacy and tolerability of risedronate once a week for the treatment of women with postmenopausal osteoporosis.
PMID 15140343·Curr Med Res Opin·2004
3-trial
Statistical validation of surrogate endpoints: is bone density a valid surrogate for fracture?
PMID 15615079·J Musculoskelet Neuronal Interact·2004
6-review
Seven years of treatment with risedronate in women with postmenopausal osteoporosis.
PMID 15455188·Calcif Tissue Int·2004
3-trial
Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate.
PMID 12817758·J Bone Miner Res·2003
3-trial
Effects of long-term risedronate on bone quality and bone turnover in women with postmenopausal osteoporosis.
PMID 12477578·Bone·2002
3-trial
Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women.
PMID 11344179·J Clin Endocrinol Metab·2001
3-trial
Positive effect of etidronate therapy is maintained after drug is terminated in patients using corticosteroids.
PMID 11748341·J Clin Densitom·2001
3-trial
Risedronate increases bone density and reduces vertebral fracture risk within one year in men on corticosteroid therapy.
PMID 11730260·Calcif Tissue Int·2001
3-trial
Improvement of pagetic bone lesions with risedronate treatment: a radiologic study.
PMID 10709999·Bone·2000
8-other
Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy.
PMID 11000340·Calcif Tissue Int·2000
3-trial
Prevention of bone loss with risedronate in glucocorticoid-treated rheumatoid arthritis patients.
PMID 10928223·Osteoporos Int·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1111 N VALLEY RD
MALVERN, PA 19355 - Phone
- (610) 296-1790
Quick Facts
- NPI
- 1831423979
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 19
Are you this provider?
Claim Your Profile